Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
30.78
-0.02 (-0.06%)
Dec 20, 2024, 4:00 PM EST - Market closed
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $2.91 billion as of December 20, 2024. Its market cap has increased by 568.49% in one year.
Market Cap
2.91B
Enterprise Value
2.43B
1-Year Change
568.49%
Ranking
Category
Stock Price
$30.78
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $2.91B, an increase of 282.95%. That is a compound annual growth rate of 43.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.91B | 319.80% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QuidelOrtho | 3.02B |
| BrightSpring Health Services | 3.01B |
| Janux Therapeutics | 2.98B |
| Xenon Pharmaceuticals | 2.95B |
| Amicus Therapeutics | 2.93B |
| Zai Lab | 2.89B |
| Merus | 2.87B |
| Twist Bioscience | 2.85B |